FindTrial
Sign In

Full-Thickness-Gastroplication For The Treatment Of Gastroesophageal Reflux Disease GERD

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01453985
Enrollment
Unknown
Registered
2011-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2011-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal Reflux Disease

Brief summary

This is a prospective study to extensively evaluate subjective patient parameters on quality of life, reflux-symptoms, side effects, medication-use and measurements of esophageal manometry and Impedance-pH-Monitoring after Full-Thickness-Gastroplication.

Interventions

PROCEDUREFull-Thickness-Gastroplication

Sponsors

General Public Hospital Zell am See
Lead SponsorOTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* persistent or recurrent symptoms despite continuous medical treatment, at least one typical reflux symptom (heartburn/ regurgitation/dysphagia/epigastric pain) and/or at least one atypical reflux symptom (cough/ asthma/hoarseness/distortion of taste), pathologic esophageal acid exposure as documented by a reflux-related DeMeester score ≥14.7, and symptom correlation ≥50%, and/or reflux episodes \>73.

Exclusion criteria

* any distinct hiatal hernia detectable by gastroscopy or barium radiography, dysphagia, esophageal strictures, poor physical status (American Society of Anesthesiologists (ASA) scores III and IV) and pregnancy.

Design outcomes

Primary

MeasureTime frame
Quality of Life—

Countries

Austria

Contacts

Primary ContactRudolph Pointner, Prof.
ac.sekretariat@kh-zellamsee.at004365427772210

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026